Degarelix injection
Products billed under this code include Firmagon.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Firmagon.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Firmagon | Ferring Pharmaceuticals Inc. | 55566-8303-01 | 80 | $360.72 |
| Firmagon | Ferring Pharmaceuticals Inc. | 55566-8403-01 | 240 | $1,082.16 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $4.509 | +$0.028 | 1 MG | Degarelix injection | v1, posted September 17, 2026 |
| 3Q26 | $4.481 | +$0.023 | 1 MG | Degarelix injection | v1, posted September 15, 2026 |
| 2Q26 | $4.458 | +$0.008 | 1 MG | Degarelix injection | v1, posted September 15, 2026 |
| 1Q26 | $4.45 | +$0.002 | 1 MG | Degarelix injection | v1, posted September 15, 2026 |
| 4Q25 | $4.448 | +$0.091 | 1 MG | Degarelix injection | v1, posted September 8, 2026 |
| 3Q25 | $4.357 | $0.00 | 1 MG | Degarelix injection | v1, posted March 10, 2026 |
| 2Q25 | $4.357 | +$0.018 | 1 MG | Degarelix injection | v1, posted March 10, 2026 |
| 1Q25 | $4.339 | +$0.163 | 1 MG | Degarelix injection | v1, posted December 19, 2025 |
| 4Q24 | $4.176 | −$0.093 | 1 MG | Degarelix injection | v1, posted June 11, 2025 |
| 3Q24 | $4.269 | −$0.084 | 1 MG | Degarelix injection | v1, posted June 11, 2025 |
| 2Q24 | $4.353 | +$0.166 | 1 MG | Degarelix injection | v1, posted March 11, 2025 |
| 1Q24 | $4.187 | +$0.06 | 1 MG | Degarelix injection | v1, posted December 19, 2024 |
| 4Q23 | $4.127 | −$0.067 | 1 MG | Degarelix injection | v1, posted October 10, 2024 |
| 3Q23 | $4.194 | +$0.13 | 1 MG | Degarelix injection | v1, posted June 5, 2024 |
| 2Q23 | $4.064 | −$0.06 | 1 MG | Degarelix injection | v1, posted February 23, 2024 |
| 1Q23 | $4.124 | +$0.047 | 1 MG | Degarelix injection | v1, posted December 6, 2023 |
| 4Q22 | $4.077 | +$0.045 | 1 MG | Degarelix injection | v1, posted June 22, 2023 |
| 3Q22 | $4.032 | −$0.017 | 1 MG | Degarelix injection | v1, posted June 9, 2023 |
| 2Q22 | $4.049 | −$0.012 | 1 MG | Degarelix injection | v1, posted December 14, 2022 |
| 1Q22 | $4.061 | −$0.059 | 1 MG | Degarelix injection | v1, posted June 8, 2022 |
| 4Q21 | $4.12 | +$0.137 | 1 MG | Degarelix injection | v1, posted June 2, 2022 |
| 3Q21 | $3.983 | −$0.017 | 1 MG | Degarelix injection | v1, posted June 2, 2022 |
| 2Q21 | $4.00 | +$0.11 | 1 MG | Degarelix injection | v1, posted March 1, 2022 |
| 1Q21 | $3.89 | – | 1 MG | Degarelix injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.